JESSICA SCHMALLE: Open Payments
NPI 1013756121 · RADCLIFF, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 17 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| ABBVIE INC. | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Abbott Laboratories | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Rybelsus, VOQUEZNA, CAPLYTA, Auvelity, QULIPTA, SPRAVATO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3.
Industry payments across KY — which companies pay providers there.
